Mitotane
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00648 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | multiple endocrine neoplasia | KG + DL |
| 2 | acne (disease) | KG + DL |
| 3 | breast fibrocystic disease | KG + DL |
| 4 | benign mammary dysplasia | KG + DL |
| 5 | seborrheic keratosis | KG + DL |
| 6 | vulvar inverted follicular keratosis | KG + DL |
| 7 | blunt duct adenosis of breast | KG + DL |
| 8 | apocrine adenosis of breast | KG + DL |
| 9 | fat necrosis of breast | KG + DL |
| 10 | breast abscess | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.